Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Fa Yi Xue Za Zhi ; 28(2): 115-9, 2012 Apr.
Artículo en Chino | MEDLINE | ID: mdl-22619807

RESUMEN

OBJECTIVE: To study the effects of ketamine and alcohol on learning and memory in mice and its possible mechanism. METHODS: Forty mice were divided into 4 groups: normal control group, ketamine group, alcohol group, and alcohol plus ketamine group. Ketamine and alcohol were given by intraperitoneal injection and intragastric administration, respectively, 1 time per day, for 14 days. The ability of learning and memory in mice was tested by the method of step-down and Morris water maze. Acetylcholine (ACh) and 5-hydroxy tryptamine(5-HT) in mice brain tissue were analyzed for the possible mechanism. RESULTS: (1) Step-down: The treatment groups lessened the latency and added wrong times (P < 0.05). The number of errors in the combined treatment group significantly increased comparing with the single drug treatment group (P < 0.05). (2) Morris water-maze: The treatment groups prolonged the latency (P < 0.05), reduced the target quadrant activity time significantly (P < 0.05), and decreased the numbers of crossing the former platform significantly (P < 0.05). (3) Biochemical index determination: The concentrations of ACh and 5-HT in treatment groups decreased significantly (P < 0.05), showed a more decreasement comparing with the single drug treatment group. CONCLUSION: Ketamine has a synergistic effect with alcohol on learning and memory impairment in mice, which may be related to the common inhibitive effect on the ACh and 5-HT.


Asunto(s)
Alcoholes/farmacología , Ketamina/farmacología , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Memoria/efectos de los fármacos , Acetilcolina/metabolismo , Alcoholes/administración & dosificación , Animales , Encéfalo/metabolismo , Encéfalo/fisiopatología , Sinergismo Farmacológico , Ketamina/administración & dosificación , Masculino , Trastornos de la Memoria/fisiopatología , Ratones , Ratones Endogámicos ICR , Serotonina/metabolismo , Conducta Espacial/efectos de los fármacos
2.
Fitoterapia ; 82(3): 383-92, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21075176

RESUMEN

This study aimed to evaluate the radioprotective effect of flavonoids extracted from the seeds of Astragalus complanatus R.Br. (FAC) and their protective mechanism against radiation damage. FAC increased the survival rate of mice and made the damaged organ injured by (60)Co γ-irradiation recovered to normal appearance with the mechanism of enhancing immune function and blood-producing function in vivo. The molecule mechanism of FAC against radiation is involved in the reduction of DNA injury and mutation in vitro. Eleven monomers of the FAC were analyzed by HPLC. These results seem to support the use of FAC in relieving radiation damage.


Asunto(s)
Planta del Astrágalo/química , Daño del ADN/efectos de los fármacos , Flavonoides/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Traumatismos por Radiación/tratamiento farmacológico , Protectores contra Radiación/uso terapéutico , Animales , Femenino , Flavonoides/farmacología , Rayos gamma , Ratones , Ratones Endogámicos , Extractos Vegetales/farmacología , Protectores contra Radiación/farmacología , Semillas
3.
Fa Yi Xue Za Zhi ; 27(6): 405-8, 412, 2011 Dec.
Artículo en Chino | MEDLINE | ID: mdl-22393586

RESUMEN

OBJECTIVE: To explore the effect of ketamine on adrenal pheochromocytoma (PC12) cell proliferation inhibition and induction of apoptosis and its mechanism. METHODS: PC12 cells of rats were models for dopaminergic neuron. PC12 cells were cultured with ketamine at concentrations of 0.9, 1.2, 1.5, 1.8 and 2.1 mmol/L, respectively. The cell viability was measured by MTT method after incubation at 12, 24, 48 and 72h. Hoechst stain was used to observe the morphological changes of apoptosis. PC12 cells cultured after 48 h with different concentrations of ketamine were selected to detect apoptotic rate using flow cytometry and detect the expression of bax and bcl-2 proteins using Western blotting. RESULTS: For different concentrations of ketamine, vitality of PC12 cells significantly decreased with increase of the incubation time. Apoptosis was obviously observed using Hoechst staining. Flow cytometry showed that apoptosis rates significantly increased with increasing ketamine concentrations. CONCLUSION: Ketamine can inhibit the proliferation of PC12 cell by inducing apoptosis of the PC12 cell in a concentrations-dependent manner. The underlying mechanism may be related to promoting the expression of bax and inhibiting the expression of bcl-2 in the cells.


Asunto(s)
Anestésicos Disociativos/farmacología , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Ketamina/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Animales , Western Blotting , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Regulación de la Expresión Génica/efectos de los fármacos , Ketamina/administración & dosificación , Células PC12 , Ratas , Factores de Tiempo , Proteína X Asociada a bcl-2/metabolismo
4.
Eur J Pharmacol ; 641(2-3): 199-206, 2010 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-20553906

RESUMEN

Epigallocatechin gallate (EGCG), the major component of polyphenols in green tea, has recently attracted considerable attention for its cardioprotective effects. Telomere signalling plays a role in regulating cardiomyocyte apoptosis during cardiac dysfunction. The purpose of this study was to investigate the effects of EGCG on oxidative stress-induced apoptosis and telomere attrition in cardiomyocytes. H9c2 cells were incubated with EGCG, 50 and 100 mg/l, for 24 h. Apoptosis induced by 200 micromol/l hydrogen dioxide (H(2)O(2)) was analyzed by DAPI nuclear staining, electron microscopy, electrophoresis of DNA fragments and flow cytometry. When H9c2 cells were incubated with H(2)O(2) for 12-24 h, the intracellular and extracellular H(2)O(2) concentrations were not affected by the presence of EGCG. Chromatin condensation, DNA fragmentation and apoptotic body formation were observed in H(2)O(2)-induced injury. Flow cytometry analysis showed that the apoptotic rate increased remarkably. EGCG significantly inhibited H(2)O(2)-induced apoptotic morphological changes and apoptotic rate. When H9c2 cells were incubated with H(2)O(2), the telomere length shortened and the protein expression of telomere repeat-binding factor 2 (TRF(2)) decreased gradually, while the protein levels of p53 and p21 increased. EGCG significantly inhibited telomere attrition, TRF(2) loss and p53, p21 upregulation induced by H(2)O(2). These results suggested that EGCG might suppress oxidative stress-induced cardiomyocyte apoptosis through inhibiting telomere dependent apoptotic pathway.


Asunto(s)
Apoptosis/efectos de los fármacos , Cardiotónicos/farmacología , Catequina/análogos & derivados , Peróxido de Hidrógeno/farmacología , Mioblastos Cardíacos/citología , Miocitos Cardíacos/efectos de los fármacos , Telómero/metabolismo , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Catequina/farmacología , Línea Celular , Células Cultivadas , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Embrión de Mamíferos , Flavonoides/química , Peróxido de Hidrógeno/metabolismo , Mioblastos Cardíacos/metabolismo , Mioblastos Cardíacos/ultraestructura , Miocitos Cardíacos/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fenoles/química , Polifenoles , Ratas , Transducción de Señal/efectos de los fármacos , Factores de Tiempo
5.
Fa Yi Xue Za Zhi ; 25(5): 348-51, 358, 2009 Oct.
Artículo en Chino | MEDLINE | ID: mdl-20000043

RESUMEN

OBJECTIVE: To explore the correlation between signs similar to schizophrenia in mice after ketamine administration and the expressions of NRG1 and ErbB4 mRNA in order to explain the possible pathogenesis of schizophrenia. METHODS: Fifty KM mice were randomly divided into 5 groups which were administered intraperitoneally with saline, clozapine and different dosages ketamine. The ketamine groups were administered intraperitoneally with low dosage (25 mg/kg), middle dosage (50 mg/kg) and high dosage (100 mg/kg) one time every day for 7 days. After administration of 100 mg/kg ketamine for 7 days, the clozapine group was introgastrically administered 20 mg/kg with clozapine one time every day for 7 days. The pathological changes of hippocampus neurons were observed by HE stain. The expressions of the NRG1 and ErbB4 mRNA in hippocampus were detected by reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: In the group with high dosage of ketamine, the levels of NRG1 and ErbB4 mRNA were significantly lower than that of the group with saline. CONCLUSION: Ketamine may induce signs similar to schizophrenia in KM mice. The mechanism may be involved in the reduction of NRG1 and ErbB4 mRNA expression.


Asunto(s)
Receptores ErbB/metabolismo , Hipocampo/metabolismo , Ketamina/efectos adversos , Neurregulina-1/metabolismo , Esquizofrenia/genética , Animales , Clozapina/uso terapéutico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Receptores ErbB/genética , Hipocampo/patología , Masculino , Ratones , Neurregulina-1/genética , Neuronas/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Distribución Aleatoria , Receptor ErbB-4 , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Esquizofrenia/inducido químicamente
6.
Fa Yi Xue Za Zhi ; 25(3): 172-5, 2009 Jun.
Artículo en Chino | MEDLINE | ID: mdl-19697772

RESUMEN

OBJECTIVE: To observe the symptoms similar to schizophrenia in mice after ketamine single or continuous injection and to evaluate the feasibility of schizophrenia model injected with different dose of ketamine. METHODS: A total of 40 male mice were randomly divided into 4 groups, which were injected intraperitoneally with physiological saline (control group), 25 mg/kg ketamine (low dose group), 50 mg/kg ketamine (middle dose group), and 100 mg/kg ketamine (high dose group) qd for 7 days continuously. The behavior changes of mice were observed. RESULTS: Hyperactivity, stereotyped behavior and ataxia (P < 0.01) were observed in high dose group after single injection. After continuous injection of ketamine for 7 days, the middle dose group showed hyperactivity, stereotyped behavior and ataxia (P < 0.05), stereotyped behavior and ataxia were more significant in high dose group (P < 0.01). CONCLUSION: Ketamine can induce the symptoms similar to schizophrenia in mice after single or continuous injection. The symptoms induced by high dose ketamine will be more prominent and stable after continuous injection.


Asunto(s)
Ketamina/administración & dosificación , Actividad Motora/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Esquizofrenia/patología , Conducta Estereotipada/efectos de los fármacos , Animales , Ataxia/inducido químicamente , Ataxia/patología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Psiquiatría Forense , Inyecciones Intraperitoneales , Masculino , Ratones , Distribución Aleatoria , Esquizofrenia/inducido químicamente
7.
Planta Med ; 75(2): 113-20, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19096994

RESUMEN

This study was carried out in order to investigate the effects of epigallocatechin gallate (EGCG) on myocardial fibrosis and cell proliferation in cardiac hypertrophy. Cardiac hypertrophy was established in rats by abdominal aortic constriction, and EGCG at doses of 25, 50 and 100 mg/kg was administered intragastrically for 6 weeks. The results showed that in the rats with cardiac hypertrophy, EGCG at 25 - 100 mg/kg dose-dependently reduced heart weight indices, decreased atrial natriuretic polypeptide and endothelin levels in plasma, but increased nitrite (the oxidative product of NO) levels in the serum and in the myocardium. EGCG also reduced the hydroxyproline concentration and decreased the proliferating cell nuclear antigen expression in the hypertrophic myocardium. EGCG remarkably inhibited pressure overload-induced c-myc increase in Western blot analysis. In cultured newborn rat cardiac fibroblasts, treatment with EGCG at 12.5 - 200 mg/L for 6 - 48 h decreased cell proliferation induced by serum. EGCG at 12.5 - 100 mg/L dose-dependently inhibited cell proliferation and DNA synthesis of fibroblasts induced by angiotensin II (Ang II) at 1 mumol/L. EGCG also significantly increased nitrite levels in culture medium, and up-regulated inducible nitric oxide synthase protein expression if compared with the Ang II group. The inhibitory effect of EGCG on cell proliferation induced by Ang II was partly blocked by pretreatment with N(omega)-nitro- L-arginine methyl ester hydrochloride. These results suggest that EGCG inhibits the proliferation of cardiac fibroblasts both in vivo and in vitro, thereby preventing myocardial fibrosis in cardiac hypertrophy. EGCG might exert its cardiac protective action through induction of NO production.


Asunto(s)
Antioxidantes/farmacología , Cardiomegalia/tratamiento farmacológico , Catequina/análogos & derivados , Proliferación Celular/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Miocardio/patología , Angiotensina II/metabolismo , Animales , Antioxidantes/uso terapéutico , Factor Natriurético Atrial/metabolismo , Camellia sinensis , Cardiomegalia/patología , Catequina/farmacología , Catequina/uso terapéutico , Proteínas de Unión al ADN/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Endotelinas/metabolismo , Inhibidores Enzimáticos/farmacología , Fibroblastos/citología , Fibrosis , Hidroxiprolina/metabolismo , Masculino , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nitritos/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/farmacología , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Sprague-Dawley , Factores de Transcripción/metabolismo
8.
Acta Pharmacol Sin ; 28(2): 191-201, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17241521

RESUMEN

AIM: To investigate the effects of epigallocatechin gallate (EGCG) on pressure overload and hydrogen peroxide (H2O2) induced cardiac myocyte apoptosis. METHODS: Cardiac hypertrophy was established in rats by abdominal aortic constriction. EGCG 25, 50 and 100 mg/kg were administered intragastrically (ig). Cultured newborn rat cardiomyocytes were preincubated with EGCG, and oxidative stress injury was induced by H2O2. RESULTS: In cardiac hypertrophy induced by AC in rats, relative to the model group, EGCG 25, 50 and 100 mg/kg ig for 6 weeks dose-dependently reduced systolic blood pressure (SBP) and heart weight indices, decreased malondialdehyde (MDA) content, and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activity, both in serum and in the myocardium. Also, treatment with EGCG 50 and 100 mg/kg markedly improved cardiac structure and inhibited fibrosis in HE and van Gieson (VG) stain, and reduced apoptotic myocytes in the hypertrophic myocardium detected by terminal transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay. In the Western blot analysis, EGCG significantly inhibited pressure overload-induced p53 increase and bcl-2 decrease. In H2O2-induced cardiomyocyte injury, when preincubated with myocytes for 6-48 h, EGCG 12.5-200 mg/L increased cell viability determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. EGCG also attenuated H2O2-induced lactate dehydrogenase (LDH) release and MDA formation. Meanwhile, EGCG 50 and 100 mg/L significantly inhibited the cardiomyocyte apoptotic rate in flow cytometry. CONCLUSION: EGCG inhibits cardiac myocyte apoptosis and oxidative stress in pressure overload induced cardiac hypertrophy. Also, EGCG prevented cardiomyocyte apoptosis from oxidative stress in vitro. The mechanism might be related to the inhibitory effects of EGCG on p53 induction and bcl-2 decrease.


Asunto(s)
Apoptosis/efectos de los fármacos , Presión Sanguínea , Cardiomegalia/tratamiento farmacológico , Catequina/análogos & derivados , Miocitos Cardíacos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Animales , Cardiomegalia/metabolismo , Cardiomegalia/patología , Catequina/farmacología , Supervivencia Celular/efectos de los fármacos , L-Lactato Deshidrogenasa/metabolismo , Masculino , Malondialdehído/análisis , Miocitos Cardíacos/patología , Tamaño de los Órganos/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/análisis , Ratas , Ratas Sprague-Dawley , Proteína p53 Supresora de Tumor/análisis
9.
Zhong Yao Cai ; 29(5): 462-4, 2006 May.
Artículo en Chino | MEDLINE | ID: mdl-16981460

RESUMEN

OBJECTIVE: To study the effects of different fractions of Modified Zhisousan (MZ, MZC, MZS) on the contents of nitric oxide (NO), endothelin-1 (ET-1) and eosinophilia (EOS) in the allergic asthma guinea pigs and observe the pathology changes of lung tissue. METHODS: The number of EOS in the blood and bronchialveolar lavage fluid (BALF) was counted by Wright staining. The contents of ET-1 and No in serum and BALF were analyzed by RIA and nitric acid reductase method. The guinea pig lungs were observed under the optical and electron microscope. RESULTS: The number of EOS and the contents of ET-1 and NO in model group were higher than those in control group (P < 0.01). The pathological changes of lung were obvious. The number of EOS and the contents of ET-1 and NO were descended remarkably (P < 0.05 or P < 0.01) and the pathological changes in the lung tissue were lightened obviously in MZ and MZC groups, but MZS group had no such effects. CONCLUSION: MZC is the effective part of MZ and the anti-asthmatic mechanisms ware related to its significant reduction in contents of ET-1, NO, EOS and the damage of lung tissue possibly.


Asunto(s)
Antiasmáticos/farmacología , Asma/patología , Medicamentos Herbarios Chinos/farmacología , Pulmón/patología , Animales , Asma/tratamiento farmacológico , Líquido del Lavado Bronquioalveolar/química , Medicamentos Herbarios Chinos/química , Endotelina-1/sangre , Eosinófilos/química , Cobayas , Recuento de Leucocitos , Ratones , Óxido Nítrico/sangre , Polvos
10.
World J Gastroenterol ; 11(37): 5782-6, 2005 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-16270385

RESUMEN

AIM: To observe the anti-liver fibrosis effect of Astragalus complanatus flavonoids (ACF) in rats. METHODS: The liver fibrosis model in rats was established by injecting interperitoneally 0.2 mL/100 g 0.5% dimethylnitrosamine, thrice a week. Meanwhile, the rats were administered ACF (30, 60, 120 mg/kg) or colchicine (0.1 mg/kg) once a day for 1 mo. Serum N-propeptide of type I procollagen (PINP) and type III procollagen (PIIINP) were measured using ELISA. Malondialdehyde (MDA) and superoxide dismutase (SOD) in hepatic tissue were evaluated. Matrix metal protease-1 (MMP-1) mRNA expression was assayed by RT-PCR and the protein expression of tissue inhibitor of metal protease-1 (TIMP-1) was analyzed by immunohistochemistry. RESULTS: In the ACF groups, SOD activity increased and MDA content decreased in comparison to the liver fibrosis model group. The serum PINP and PIIINP contents in ACF-2 and -3 group decreased compared to those in model group. In ACF-2 and -3 group, the expression of MMP-1 mRNA increased significantly and the protein expression of TIMP-1 decreased compared to that in model group. CONCLUSION: The antifibrotic mechanisms of ACF are associated with its influence on lipid peroxidation and collagen synthesis and degradation.


Asunto(s)
Planta del Astrágalo/química , Fibrosis/tratamiento farmacológico , Flavonoides , Cirrosis Hepática Experimental , Preparaciones de Plantas , Animales , Colágeno Tipo I/sangre , Colágeno Tipo I/genética , Colágeno Tipo III/sangre , Colágeno Tipo III/genética , Fibrosis/metabolismo , Fibrosis/patología , Flavonoides/química , Flavonoides/uso terapéutico , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática Experimental/tratamiento farmacológico , Cirrosis Hepática Experimental/patología , Masculino , Malondialdehído/metabolismo , Metaloproteinasa 1 de la Matriz/genética , Metaloproteinasa 1 de la Matriz/metabolismo , Medicina Tradicional China , Fitoterapia , Preparaciones de Plantas/química , Preparaciones de Plantas/uso terapéutico , Procolágeno/sangre , Procolágeno/genética , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Inhibidor Tisular de Metaloproteinasa-1/metabolismo
11.
Acta Pharmacol Sin ; 23(7): 597-600, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12100751

RESUMEN

AIM: To investigate the mechanism of xiaoyu tablet on reduction of smooth muscle cells (SMC) in atherosclerotic vessel wall. METHODS: The atherosclerotic model was performed in male New Zealand rabbits that were given high fat diet and abrasion of the abdominal aorta endothelial cells. The rabbits were then administered with xiaoyu tablet 0.16-0.32 g x kg(-1) x d(-1) for 16 weeks. Changes in morphology, endothelin (ET)-1, nitric oxide (NO), and apoptotic cells of atherosclerotic vessel wall were determined by the microscopy, radioimmunoassay, colorimetric method, the techniques of DNA in situ end labeling, and image pattern analysis, respectively. RESULTS: After 16 weeks of xiaoyu tablet treatment, intimal thickness and SMC in atherosclerotic vessel wall were diminished, ET-1 was decreased by 8.2 %-42.6 %, NO was increased by 7.5 %-54.2 %, and labeled apoptotic nuclei were markedly decreased, the area and integral optical density of positive granule were (846+/-308) microm2 and 3425+/-1374 in atherosclerotic group and (225+/-60) microm2 and 1445+/-606 in xiaoyu tablet 0.32 g/kg group, respectively. CONCLUSION: Xiaoyu tablet not only inhibited proliferation of SMC through reducing ET-1 in atherosclerotic vessel wall, but also induced apoptosis of SMC by increasing NO in vessel wall.


Asunto(s)
Apoptosis/efectos de los fármacos , Arteriosclerosis/patología , Medicamentos Herbarios Chinos/farmacología , Endotelina-1/metabolismo , Óxido Nítrico/metabolismo , Animales , Aorta Abdominal/metabolismo , Aorta Abdominal/patología , Arteriosclerosis/etiología , Arteriosclerosis/metabolismo , Crataegus/química , Combinación de Medicamentos , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/aislamiento & purificación , Masculino , Músculo Liso Vascular/patología , Plantas Medicinales/química , Conejos , Salvia miltiorrhiza/química , Comprimidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA